Reviva Pharmaceuticals HoldiRVPH
13F holders, Q4 2025 (December 31)1holders
$0.34avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Reviva Pharmaceuticals Holdi (RVPH) in their 13F filings. The largest holder was EMC Capital Management ($44K).
- Company
- Reviva Pharmaceuticals Holdi
- CUSIP
- 76152G209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $44K |
| Exits | 0 | $0 |
Ownership 1 holders
| EMC Capital Management | 0.02% | New | 128,915 | $44K |
"% of holder's portfolio" is RVPH's weight in each manager's 13F, not the share of Reviva Pharmaceuticals Holdi the manager owns.